A Global Leading Supplier of In Vitro Diagnostic Solutions
Since the establishment in 2012, Vazyme has been dedicated to our mission "Science and Technology Make a Healthier Life" to focus on technology innovation and continuously develop eight series of proprietary POCT diagnostic reagents and related control materials covering cardiovascular and cerebrovascular diseases, inflammation, prepotency, gastric functions, autoimmunity, renal functions, chronic disease management as well as respiratory diseases. As a R&D based company, we have been holding ourselves to the highest standards of ethics, accountability and professionalism. Our global research and development operations make sure we could provide quality products, solutions, and services locally to our customers, and more importantly, to do as much as it can to meet the unmet medical needs. For now, we are present in more than 60 countries and regions worldwide to get close to local customers.
Innovation is our DNA
make up our global research and development operations with scientists, experts, bio-technicians, medical specialists, engineers, and software developers.
We have kept devoting ourselves as a committed frontrunner in technology innovation. We are a R&D focused innovative biotechnology company with both capabilities in developing in-house upstream technologies and manufacturing end products.
has been invested in R&D projects, people and equipment for these years. Now we have 25,000㎡ R&D center and company headquarter, 64,000㎡ biological reagents and raw materials production base and IVD production line with GMP workshop.
have been published by Vazyme in top academic journals worldwide, including more than 260 in CNS ( stands for Cell, Nature, Science ) and its sub-journals, as of Nov 2021.
4 Key Technology Platforms
which are independently established by ourselves are the foundation for our products, solutions, and services.
Protein Directed Modification & Evolution Platform For high-end products: Improved products performance via leading-edge technology platform
High Performance Antibody Discovery Platform (Based on Single B Cell) For difficult and scarce products: Enhance antibody screening efficiency and shorten development cycle
Multi-system Recombinant Protein Preparation Platform For safer supply chain: Increase the unit production capacity to world leading level
Quantum Dot Modified Coupling and Multi-index Joint Inspection Technology Platform For higher efficiency with lower cost: Multiple test results for one sample in one step
University cooperation Talents are a key driver of research and development. Committed to empowering healthy living with technical innovations, we team up with universities to build a platform for academic exchanges, resource sharing and talent development.
Public health Science and Technology Make a Healthier Life is not just a slogan; it is a commitment to our society and the whole world. To help humans overcome epidemics, tumors, and autoimmune diseases, we played an important role in the fight against the African swine flu and COVID-19. We are among the first to roll out COVID-19 testing solutions. As of Feb 2022, we provided detection kit manufacturers with key raw materials that could be used for about 1.2 billion tests. So far, our testing kits have made their way to more than 60 countries.
Subscribe to our Newsletter
Our vision is to lead in biotechnology by driving innovation relentlessly, pursuing the highest standards in quality of products and services, and creating value for our customers.